DOCSLIB.ORG

ABCDEF LAST UPDATED: 05/28/2014 This Reflects the Last Date of Any Changes Made to the List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ABCDEF LAST UPDATED: 05/28/2014 This Reflects the Last Date of Any Changes Made to the List ABCDEF LAST UPDATED: 05/28/2014 This reflects the last date of any changes made to the list. Authorized Distributors Below is a list of Roxane Laboratories, Inc. (RLI) Authorized Distributors. These distributors have met RLI's requirements to distribute RLI's products. Authorized Distributors listed below are approved to distribute the entire RLI product line provided that they have the appropriate licenses. AmerisourceBergen Drug Corp AmerisourceBergen Drug Corp 172 Cahaba Valley Pkwy PELHAM AL AmerisourceBergen Drug Corp 1825 S 43rd Ave STE B PHOENIX AZ AmerisourceBergen Drug Corp 1851 California Ave CORONA CA AmerisourceBergen Drug Corp 1325 W Striker Ave SACRAMENTO CA AmerisourceBergen Drug Corp 24903 Avenue Kearny VALENCIA CA AmerisourceBergen Drug Corp 501 W 44th Ave DENVER CO AmerisourceBergen Drug Corp 2100 Directors Row ORLANDO FL AmerisourceBergen Drug Corp 1085 N Satellite Blvd SUWANEE GA AmerisourceBergen Drug Corp 238 Sand Island Access Rd #M1 HONOLULU HI AmerisourceBergen Drug Corp 1001 W TAYLOR RD ROMEOVILLE IL AmerisourceBergen Drug Corp 322 N 3RD St PADUCAH KY AmerisourceBergen Drug Corp 101 Norfolk St MANSFIELD MA AmerisourceBergen Drug Corp One Industrial Park Dr WILLIAMSTON MI AmerisourceBergen Drug Corp 6810 Shady Oak Rd EDEN PRAIRIE MN AmerisourceBergen Drug Corp 11200 N CONGRESS AVE KANSAS CITY MO AmerisourceBergen Drug Corp 8190 Lackland Rd SAINT LOUIS MO AmerisourceBergen Drug Corp 6300 St Louis St MERIDIAN MS AmerisourceBergen Drug Corp 8605 Ebenezer Church Rd RALEIGH NC AmerisourceBergen Drug Corp 100 Friars Blvd THOROFARE NJ AmerisourceBergen Drug Corp 1200 E Fifth Ave COLUMBUS OH AmerisourceBergen Drug Corp 6305 LASALLE DR LOCKBOURNE OH AmerisourceBergen Drug Corp 9401 E 54Th St TULSA OK AmerisourceBergen Drug Corp 5100 JAINDL BLVD BETHLEHEM PA J M Blanco Inc 21-D Amelia Industrial Pk GUAYNABO PR AmerisourceBergen Drug Corp 12980 Old Hickory Blvd ANTIOCH TN AmerisourceBergen Drug Corp 501 PATRIOT PARKWAY ROANOKE TX AmerisourceBergen Drug Corp 12727 W Airport Blvd SUGAR LAND TX AmerisourceBergen Drug Corp 1765 Fremont Dr SALT LAKE CITY UT AmerisourceBergen Drug Corp 9900 Jeb Stuart Pkwy GLEN ALLEN VA AmerisourceBergen Drug Corp 19220 64th Ave S KENT WA Anda Generics Inc Anda Generics Inc 2915 Weston Rd Weston FL Anda Generics Inc 6500 ADELAIDE CT GROVEPORT OH Associated Pharmacies Inc Associated Pharmacies Inc 211 Lonnie Crawford Blvd Scottsboro AL Auburn Pharmaceutical Corp Auburn Pharmaceutical Corp 1775 John R Rd TROY MI Bellco Drug Corp Bellco Drug Corp 5500 New Horizons Blvd NORTH AMITYVILLE NY Bloodworth Wholesale Drugs BLOODWORTH WHOLESALE DRUGS 2128 YANK LAMB DR PO BOX 1849 TIFTON GA Borschow Hosp & Medical Supplies CENTRO INT'L DE DIST ZONA LIBRE DE BORSCHOW HOSP & MED SUPPLIES NBW2 COMERCIO GUAYNABO PR Burlington Drug Company Burlington Drug Company 91 Catamount Dr MILTON VT Capital Wholesale Drug Capital Wholesale Drug 873 Williams Ave GRANDVIEW HEIGHTOH 1 ABCDEF LAST UPDATED: 05/28/2014 This reflects the last date of any changes made to the list. Authorized Distributors Below is a list of Roxane Laboratories, Inc. (RLI) Authorized Distributors. These distributors have met RLI's requirements to distribute RLI's products. Authorized Distributors listed below are approved to distribute the entire RLI product line provided that they have the appropriate licenses. Cardinal Health Cardinal Health 600 N 83rd Ave TOLLESON AZ Cardinal Health 3950 VALLEY E. INDUSTRIAL BLVD BIRMINGHAM AL Cardinal Health 3238 Dwight Rd ELK GROVE CA Cardinal Health 27680 Ave Mentry VALENCIA CA Cardinal Health 4875 Florence St DENVER CO Cardinal Health 2045 Interstate Dr LAKELAND FL Cardinal Health 500 Jerry Steele Ln MCDONOUGH GA Cardinal Health 2353 Prospect Dr AURORA IL Cardinal Health 10 KINGBROOK PKWY SIMPSONVILLE KY Cardinal Health 11 Centennial Dr PEABODY MA Cardinal Health 7601 NE Gardner Ave KANSAS CITY MO Cardinal Health 2840 Elm Point Industrial Dr SAINT CHARLES MO Cardinal Health 1240 Gluckstadt Rd MADISON MS Cardinal Health 4 Cardinal Health Ct GREENSBORO NC Cardinal Health 1120 Commerce Blvd SWEDESBORO NJ Cardinal Health 6012 Molloy Rd SYRACUSE NY Cardinal Health 14601 County Road 212 FINDLAY OH Cardinal Health 850 AIRPORT DISTRIBUTION DR ZANESVILLE OH Cardinal Health 2512 West Cott Blvd KNOXVILLE TN Cardinal Health 401 Mason Rd LA VERGNE TN Cardinal Health 851 Henrietta Creek Rd ROANOKE TX Cardinal Health 13651 Dublin Ct Stafford TX Cardinal Health 955 W 3100 S SALT LAKE CITY UT Cardinal Health 801 C St NW Suite B AUBURN WA Cardinal Health 2901 Enloe St HUDSON WI Cardinal Health 71 Mil Acres Dr WHEELING WV Cesar Castillo Inc CESAR CASTILLO INC CARR #1, KM 21.1 LA MUDA GUAYNABO PR CVS CVS Distribution 2572-77 98TH AVE VERO BEACH FL CVS Distribution 700 CVS DR ENNIS TX CVS Distribution 100 S TRADE CENTER PKWY CONROE TX CVS Distribution 7590 Empire Dr INDIANAPOLIS IN CVS Distribution 150 Industrial Dr NORTH SMITHFIELD RI CVS Distribution 10017 Kingston Pike KNOXVILLE TN CVS Distribution 777 S HARBOR BLVD LA HABRA CA CVS Distribution 8201 CHANCELLOR DR ORLANDO FL CVS Distribution 3 Berry Dr LUMBERTON NJ CVS Distribution 2400 Keystone Pacific Prkwy PATTERSON CA CVS Distribution 5721 E. Santa Ana St. Unit E ONTARIO CA Dakota Drug Inc Dakota Drug Inc 4121 12th Ave NW FARGO ND Dakota Drug Inc 28 N Main St MINOT ND Diamond Pharmacy Diamond Pharmacy 645 Kolter Drive Indiana PA Dik Drug Company Inc Dik Drug Company 160 Tower Dr BURR RIDGE IL Dms Pharmaceutical Group Inc Dms Pharmaceutical Group Inc 810 Busse Hwy PARK RIDGE IL Drogueria Betances Inc Drogueria Betances Inc Urb Indust Cartagena CARR. #1 KM 34.0 CAGUAS PR Drugs Unlimited Inc Drugs Unlimited Inc Acacia #3 URB Monte Rey Pueblo Viejo SAN JUAN PR 2 ABCDEF LAST UPDATED: 05/28/2014 This reflects the last date of any changes made to the list. Authorized Distributors Below is a list of Roxane Laboratories, Inc. (RLI) Authorized Distributors. These distributors have met RLI's requirements to distribute RLI's products. Authorized Distributors listed below are approved to distribute the entire RLI product line provided that they have the appropriate licenses. Expert-Med Inc EXPERT MED 400 ANDALUSIA AVE ORMOND BEACH FL EXPERT-MED INC 101-B PARK PLACE CT GREENVILLE SC Frank W Kerr Co Frank W Kerr Co 43155 W Nine Mile Rd NOVI MI Gen-Source Rx Gen-Source Rx 620 Gotham Parkway CARLSTADT NJ Genetco Inc Genetco Inc 711 Union Pky RONKONKOMA NY Great Lakes Harvard Drug Co Harvard Drug Group LLC 8330 Arjons Dr SAN DIEGO CA Major Pharmaceuticals 5110 W 74Th St INDIANAPOLIS IN Great Lakes Harvard Drug Co 31778 Enterprise Dr LIVONIA MI H D Smith Wholesale Drug Co H D Smith Wholesale Drug Co 740 Glasgow Ave INGLEWOOD CA H D Smith Wholesale Drug Co 1901 NORTHWEST 25TH AVE POMPANO BEACH FL H D Smith Wholesale Drug Co 3063 FIAT AVE SPRINGFIELD IL H D Smith Wholesale Drug Co 4650 Industrial Dr SPRINGFIELD IL H D Smith Wholesale Drug Co 950 Lively Blvd WOOD DALE IL H D Smith Wholesale Drug Co 8 Marin Way Stratham NH H D Smith Wholesale Drug Co 410 Commerce Blvd - Unit B CARLSTADT NJ H D Smith Wholesale Drug Co 1101 W Vickery Blvd FORT WORTH TX Hannaford Brothers Co. Progressive Distributor Rt 202 WINTHROP ME Henry Schein Inc Henry Schein Inc 8691 Jesse B Smith Court JACKSONVILLE FL Henry Schein Inc 5315 West 74th St INDIANAPOLIS IN Henry Schein Inc 255 Vista Blvd SPARKS NV Henry Schein Inc 41 Heaver Rd DENVER PA Henry Schein Inc 1001 Nolen Dr Suite 400 Grapevine TX Kaiser Permanente Kaiser Foundation Hosp 9521-D Dalen St Downey CA KAISER FOUNDATION HOSPITALS 5800 COLISEUM WAY Oakland CA King Drug Co King Drug Co 605 W Lucas St FLORENCE SC Kinray Inc Kinray Inc 152 35 10th Ave WHITESTONE NY Kinney Drugs Kinney Drugs 520 E MAIN S GOUVERNEUR NY Kroger Co Kroger Co 1111 S Adams St Bluffton IN Kroger Co 5305 W Buckeye Rd Phoenix AZ Kroger Co 153 Refreshment Ln Cleveland TM Louisiana Wholesale Drug Co Louisiana Wholesale Drug Co 1611 Olive St MONROE LA Louisiana Wholesale Drug Co 2085 I49 S Service Rd SUNSET LA 3 ABCDEF LAST UPDATED: 05/28/2014 This reflects the last date of any changes made to the list. Authorized Distributors Below is a list of Roxane Laboratories, Inc. (RLI) Authorized Distributors. These distributors have met RLI's requirements to distribute RLI's products. Authorized Distributors listed below are approved to distribute the entire RLI product line provided that they have the appropriate licenses. McKesson Corporation McKesson Corporation 5491 Electron Dr Suite A ANCHORAGE AK McKesson Corporation 6775 Jefferson Metropolitain Mccalla AL McKesson Corporation 495 S 107th Tolleson AZ McKesson Corporation 9501 Norwalk Blvd SANTA FE SPRINGS CA McKesson Corporation 3775 Seaport Blvd WEST SACRAMENTOCA McKesson Corporation 14500 E 39th Ave AURORA CO McKesson Corporation 280 Dividend Rd ROCKY HILL CT McKesson Corporation 1515 W Bella Vista St LAKELAND FL McKesson Corporation 2975 Evergreen Dr DULUTH GA McKesson Corporation 80 Sand Island Access Rd HONOLULU HI McKesson Corporation 520 E North Ave CAROL STREAM IL McKesson Corporation 9 Aegean Dr METHUEN MA McKesson Corporation 7721 Polk St LANDOVER MD McKesson Corporation 38220 Plymouth Rd LIVONIA MI McKesson Corporation 3230 Spruce St SAINT PAUL MN McKesson Corporation 1823 RUST AVE CAPE GIRARDEAU MO McKesson Corporation 1 Commerce Dr O'FALLON MO McKesson Corporation 7009 S 108th St LA VISTA NE McKesson Corporation 400 Delran Pkwy DELRAN NJ McKesson Corporation 2700 North America Dr WEST SENECA NY McKesson Corporation 3000 KENSKILL AVE WASHINGTON OH McKesson Corporation 4012 S Purdue OKLAHOMA CITY OK McKesson Corporation
Load more

Recommended publications
  • Safe and Secure Distribution of Controlled Substances September 2019 About This Report
    Safe and Secure Distribution of Controlled Substances September 2019 About This Report AmerisourceBergen exists within a highly AmerisourceBergen is publishing this report complex and dynamic healthcare environment. both to build on the Company’s commitment to We provide both our partners and the healthcare transparency and to provide stockholders and other system deep scale, efficiency, and value. Our wholesale stakeholders information on our efforts to ensure pharmaceutical distribution business plays a key role the safe and secure distribution of opioids and in the pharmaceutical supply chain, providing safe other controlled substances, as well as information access to thousands of important medications for on the community and associated outreach healthcare providers to serve patients with a wide programs AmerisourceBergen created and supports array of clinical needs across the healthcare spectrum. to help combat the opioid epidemic. This report supplements our efforts to communicate with The driving force behind everything we do is our stakeholders through our Corporate Citizenship Purpose - we are united in our responsibility to create Report, proxy materials, and the Fighting the Opioid healthier futures. This Purpose drives every facet of Epidemic section of our website1 and supports our our business and is more important today than ever ongoing dialogue through direct engagement. as we and the country grapple with the opioid crisis. AmerisourceBergen welcomes the opportunity AmerisourceBergen has a longstanding commitment to provide this information and the Company is to ensuring a safe and efficient pharmaceutical committed to continued transparency. supply chain. We have taken substantial steps to combat the diversion of controlled substances and fight opioid misuse and abuse.
    [Show full text]
  • Name Address City Zip AMERISOURCEBERGEN CORP
    Name Address City Zip AMERISOURCEBERGEN CORP 322 N 3RD ST PADUCAH 42001 AMERISOURCEBERGEN CORP 6810 SHADY OAK RD EDEN PRAIRIE 55344 AMERISOURCEBERGEN CORP 172 CAHABA VALLEY PKY PELHAM 35124 AMERISOURCEBERGEN CORP 6305 LASALLE DR LOCKBOURNE 43137 AMERISOURCEBERGEN CORP 501 PATRIOT PKWY ROANOKE 76262 AMERISOURCEBERGEN CORP 1001 W TAYLOR RD ROMEOVILLE 60446 AMERISOURCEBERGEN CORP 11200 NORTH CONGRESS AVE KANSAS CITY 64153 AMERISOURCEBERGEN CORP 5100 JAINDL BLVD BETHLEHEM 18017 AMERISOURCEBERGEN CORP 004 101 NORFOLK ST MANSFIELD 2048 AMERISOURCEBERGEN CORP 008 1325 W STRIKER AVE SACRAMENTO 95834‐1164 AMERISOURCEBERGEN CORP 012 1851 CALIFORNIA AVE CORONA 92881 AMERISOURCEBERGEN CORP 017 1765 FREMONT DR SALT LAKE CITY 84104 AMERISOURCEBERGEN CORP 020 1825 S 43RD AVE PHOENIX 85009 AMERISOURCEBERGEN CORP 024 24903 AVE KEARNY VALENCIA 91355 AMERISOURCEBERGEN CORP 026 238 SAND ISLAND ACCESS RD #M‐1 HONOLULU 96819 AMERISOURCEBERGEN CORP 032 19220 64TH AVE SOUTH KENT 98032 AMERISOURCEBERGEN CORP 037 12727 W AIRPORT BLVD SUGAR LAND 77478 AMERISOURCEBERGEN CORP 038 501 W 44TH AVE DENVER 80216 AMERISOURCEBERGEN CORP 040 1085 N SATELLITE BLVD SUWANEE 30024 AMERISOURCEBERGEN CORP 041 9900 JEB STUART PKWY GLEN ALLEN 23059 AMERISOURCEBERGEN CORP 049 ONE INDUSTRIAL PARK DR WILLIAMSTON 48895 AMERISOURCEBERGEN DRUG CO 120 TRANS AIR DR MORRISVILLE 27560 AMERISOURCEBERGEN DRUG CORP 2100 DIRECTORS ROW ORLANDO 32809‐6234 AMERISOURCEBERGEN DRUG CORP 10910 VISTA BLVD SUITE 401 ORLANDO 32829 ASD SPECIALTY HEALTHCARE ABC 345 INTERNATIONAL BLVD STE 400 BROOKS 40109
    [Show full text]
  • BNYM Investment Port:Midcap Stock Port (Unaudited) As of Date: 09/30/2020 Common Stocks
    BNYM Investment Port:MidCap Stock Port (Unaudited) As of date: 09/30/2020 Common Stocks Identifier Security Description Shares Market Value ($) 002535300 Aaron's 7,450 422,043 00404A109 Acadia Healthcare 5,480 161,550 004498101 ACI Worldwide 13,250 346,223 00508Y102 Acuity Brands 9,470 969,255 BD845X2 Adient 12,480 216,278 00737L103 Adtalem Global Education 6,800 166,872 00766T100 AECOM 4,170 174,473 018581108 Alliance Data Systems 7,130 299,317 01973R101 Allison Transmission Holdings 7,110 249,845 00164V103 AMC Networks 10,710 264,644 023436108 Amedisys 2,760 652,547 025932104 American Financial Group 3,310 221,704 03073E105 AmerisourceBergen 2,220 215,162 042735100 Arrow Electronics 5,620 442,069 04280A100 Arrowhead Pharmaceuticals 5,670 244,150 045487105 Associated Banc-Corp 47,940 605,003 05329W102 Autonation 6,980 369,451 05368V106 Avient 23,030 609,374 053774105 Avis Budget Group 10,600 278,992 05464C101 Axon Enterprise 2,410 218,587 062540109 Bank of Hawaii 4,830 244,012 06417N103 Bank OZK 6,630 141,352 090572207 Bio-Rad Laboratories 1,480 762,881 09073M104 Bio-Techne 880 218,002 05550J101 BJs Wholesale Club Holdings 11,270 468,269 09227Q100 Blackbaud 3,750 209,363 103304101 Boyd Gaming 18,350 563,162 105368203 Brandywine Realty Trust 93,500 966,790 11120U105 Brixmor Property Group 6,300 73,647 117043109 Brunswick 8,150 480,117 12685J105 Cable One 300 565,629 127190304 CACI International, Cl. A 3,980 848,377 12769G100 Caesars Entertainment 11,890 666,553 133131102 Camden Property Trust 11,390 1,013,482 134429109 Campbell Soup 4,440
    [Show full text]
  • Generics Breakout Welcome
    Generics Breakout Welcome David Picard Senior Vice President, Global Generic Pharmaceuticals Discussion Agenda • CERTIO Enhancements • American Health Packaging Alan Ratliff, Director, Supplier Trade o Kyle Pudenz, Senior Vice President, o Manufacturer and Data Services Relations • Generic Sourcing • Stable Supply Initiative o Chris Doerr, Vice President, Global o Heather Ryan, Senior Manager, Drug Shortage Generic Sourcing Solutions • Q&A SM • SureSupply o Heather Odenwelder, Senior Director, Category Management o Charles Hartenstine, Senior Director, Category Management CERTIO 2020 AmerisourceBergen Switzerland Kyle Pudenz Senior Vice President, Manufacturer and Data Services CERTIO® 2020 Evolving the CERTIO solution to address key business challenges. Further Supply Chain Integration Support Proactive Communication Easier to Use Project Overview Working with key stakeholders to address your business needs CERTIO 2020 Kickoff CERTIO Champions Sessions December 14 2019 Unique CERTIO Champions 108+ 9 Engaged CERTIO Users November Enhanced CERTIO 9 Dashboards 90+ CERTIO 2020 Launch CERTIO® 2020 and Beyond Continuing to shape your preferred supply chain solution • Launching November 9, 2020 o No change in current functionality Contact Upcoming training opportunities o [email protected] • Platform Evolution 2021 o Product Oversight o Failure to Supply o …and more! Special thanks to our CERTIO® Champions! Manufacturer Partners AmerisourceBergen Ajanta Lannett Global Generics Leadership Alembic Lupin Category Management Apotex Mallinckrodt
    [Show full text]
  • Women in Leadership 2018 a Status Report on Women Leaders in Corporate Boardrooms and Executive Offices
    Women in Leadership 2018 A Status Report on Women Leaders in Corporate Boardrooms and Executive Offices The Forum of Executive Women Philadelphia, PA 2018–2019 About The Forum of Executive Women Board of Directors Founded in 1977, The Forum of Executive Women is a membership organization of more than 450 women of significant influence Officers across the Greater Philadelphia region. The Forum’s membership Margaret A. McCausland consists of individuals holding the senior-most positions in President the corporations, nonprofit organizations and public sector entities that drive our regional economy and community. Lisa Detwiler Vice President The Forum’s members are executive women working together Katherine Hatton to increase the number of women in leadership roles, expand Secretary their impact and influence, and position them to drive positive change in the region. We have served as the catalyst for a Shannon Breuer multitude of initiatives that have sparked critical conversations Treasurer in executive suites, boardrooms and public policy arenas. Forum programs and initiatives include symposiums, CEO At-Large Directors Roundtables, a Public Sector Leadership Conversation Series, and Committee Chairs publication of research reports, and outreach promoting the value Jeanne S. Barnum of gender diversity on boards and in executive suites. A robust Yelena M. Barychev mentoring program with diverse initiatives enhances The Forum’s Emily V. Biscardi commitment to building the pipeline of our next generation of Teresa Bryce Bazemore women leaders in the tri-state Greater Philadelphia region. Joan F. Chrestay Diane M. Connor Tanuja M. Dehne Nancy O’Mara Ezold The Forum of Executive Women Debra Fickler 1231 Highland Avenue Amy S.
    [Show full text]
  • Sotrovimab Access Guide
    Access & Reimbursement Information for Sotrovimab June 2021 AUTHORIZED USE Sotrovimab is authorized for use under an Emergency Use Authorization (EUA) for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. LIMITATIONS OF AUTHORIZED USE • Sotrovimab is not authorized for use in patients: who are hospitalized due to COVID-19, OR who require oxygen therapy due to COVID-19, OR who require an increase in baseline oxygen flow rate due to COVID-19 (in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity). • Benefit of treatment with sotrovimab has not been observed in patients hospitalized due to COVID-19. SARS-CoV-2 monoclonal antibodies may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation. Sotrovimab is not FDA-approved and is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of sotrovimab under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Please see Important Safety Information, most current Fact Sheet for Healthcare Providers and Fact Sheet for Patients, Parents, and Caregivers, and FDA Letter of Authorization
    [Show full text]
  • 7/7/2020 FAQ Regarding Upcoming Commercial Remdesivir Allocation
    7/7/2020 FAQ Regarding Upcoming Commercial Remdesivir Allocation On June 29, 2020, the Department of Health and Human Services (HHS) announced an agreement with Gilead Sciences to secure 500,000 treatment courses of commercial remdesivir for American hospitals through September 2020. In contrast to the previous donated supply of remdesivir, this supply will be purchased by American hospitals. On Friday July 3, 2020, the HHS Office of the Assistant Secretary for Preparedness and Response (HHS/ASPR) announced further details on the upcoming allocation process, as summarized in the following figure: On Monday July 6, 2020, representative members of the Society of Infectious Diseases Pharmacists (SIDP) met with ASPR and AmerisourceBergen (sole distributor of remdesivir) to clarify frequently asked questions regarding this upcoming process. Frequently Asked Questions • What price should American hospitals expect to pay for commercial remdesivir when ordering from AmerisourceBergen? Most American hospitals should expect to pay the wholesale acquisition cost (WAC) of $520 per 100 mg vial of remdesivir. For a typical 5-day course of remdesivir (total of 6 vials), this would equate to $3,120 per course. The government price of $390 per vial is applicable to federal agencies that directly purchase drugs, such as the Veterans’ Affairs, Indian Health Services, Department of Defense, the Coast Guard and the Federal Bureau of Prisons, once on the Federal Supply Schedule, and will not apply to most American hospitals. • Per ASPR, state level allocations of commercial remdesivir will be based on American hospitals reporting data on suspected or confirmed COVID-19 cases every 2 weeks via the TeleTracking portal.
    [Show full text]
  • President's Message Inside 4Q2019
    Inside 4Q2019 2.......Template.for.Disaster 8.......Past.Events 3.......ACC.News 15.....Sponsors.for.2019 4.......Choice.of.Law.and.Covenants.. 16.....New.and.Returning.Members Not.to.Compete 18.....Upcoming.ACCGP.Events 5.......Member.Spotlight 18.....Chapter.Leadership 6.......Aileen.Schwartz.Forges.Relationships,.. Inspires.Change 7.......Association.of.Corporate.. Counsel’sTop.10.30-Somethings FOCUS President’s Message Peter A. Prinsen I am advised by our Membership Chair, Speaking of 2020, I’m thrilled CLE Institute on December Mike Eckhardt from Wawa, that the Greater to report that we have had an 10th, Morgan Lewis’ sponsor- Philadelphia Chapter’s membership is now at overwhelming response to our ship of Pro Bono efforts with over 1,600 members. Not only is the number 2020 sponsorship opportunities. Philadelphia VIP on December of our Chapter members outstanding, but the Like last year, we have been 11th and culminating with level of your involvement and commitment to oversubscribed in virtually all sponsorship our Annual Holiday Party and Board the Chapter is extraordinary as well. This year levels. Despite being oversubscribed, we Installation on December 12th at the we will have put on over 80 programs ranging continue to work hard to find opportunities Racquet Club of Philadelphia. from our Meet your Counterparts Programs for our sponsors to “squeeze them in” so that I am truly humbled to have been your to our In-House Counsel Conference (where they can enjoy the benefit of sponsorship of President for 2019. For 2020, the Chapter over 600 of you attended and participated in this fine Chapter.
    [Show full text]
  • Program on Topics of Executive Communication and Advanced Persuasion
    The 7th Annual Philadelphia The Pennsylvania Diversity Council presents Diversity & Inclusion 2.0: Aligning Purpose, People & Performance September 1, 2016 8:30am - 3:00pm Hilton Philadelphia City Avenue 4200 City Avenue Philadelphia, Pennsylvania 19131 HELPING MORE PEOPLE ACHIEVE THEIR DREAM OF HOMEOWNERSHIP At Radian, we are committed to helping people achieve their dream of homeownership. For nearly 40 years, we have been working diligently with our lending partners to find innovative solutions to make this dream a reality for more deserving homebuyers. To learn more or to partner with Radian, please visit radian.biz. Radian is proud to support the 7th Annual Philadelphia Diversity & Leadership Conference. www.radian.biz 877.723.4261 Visit our new homebuyer website at AchieveTheDream.com to see how we are helping first-time homebuyers navigate the process with ease! © 2016 Radian Guaranty Inc. WELCOME FROM THE NATIONAL DIVERSITY COUNCIL DENNIS KENNEDY ANGELES VALENCIANO Founder & Chairman CEO National Diversity Council National Diversity Council We are truly honored to welcome you to the 7th Annual Philadelphia Diversity & Leadership Conference. As the country faces ever-changing demographics, new opportunities have risen for organizations to create a diverse and inclusive environment in order to foster innovation and leadership excellence. The purpose of today’s event is to ensure companies possess the tools they need for success by sharing diversity and inclusion best practices and essential leadership skills. The Diversity & Leadership Conference is comprised of an opening awards breakfast, several breakout panel sessions, and awards luncheon. Throughout the conference, speakers will openly discuss topics relating to the event theme of “Diversity & Inclusion 2.0: Aligning Purpose, People, and Performance.” We will also have the honor of recognizing several influential business executives who have exemplified leadership excellence and championed diversity and inclusion throughout their careers.
    [Show full text]
  • Comcast Technology Center Opens
    Press Contact: Marlene K. Sahms T 610.755.6930 [email protected] FOR IMMEDIATE RELEASE Comcast Technology Center Opens Philadelphia, PA (July 24, 2018) — Newmark Knight Frank (NKF) released its second-quarter 2018 office reports for the greater Philadelphia region. The reports detail no slowdown in activity for Southeastern Pennsylvania, while the delivery of the Comcast Technology Center results in the Philadelphia Central Business District (CBD) recording over 1.0 million square feet of positive absorption. Both Delaware's suburban submarkets and the Southern New Jersey market struggle with rising vacancy. Southeastern Pennsylvania recorded 709,719 square feet of positive absorption for the first half of the year and surpassed 2017’s year-end absorption by 148,000 square feet. Overall vacancy decreased 60 basis points quarter-over- quarter to 14.0 percent. USSC Group’s expansion into 300,000-square-foot at 101 Gordon Drive, located in the Exton/Malvern submarket, accounted for most of the quarter’s 355,000 square feet of absorption. On the downside, some suburban tenants decided to shed excess space, which pushed year-over-year sublease availability up 10 basis points to 2.0 percent. In the Fort Washington submarket, T-Mobile relocated and downsized from 45,000 square feet at 500 Virginia Drive to 24,112 square feet at 475 Virginia Drive. Transamerica, located in the Exton/Malvern submarket, outsourced a number of business line jobs to a third-party provider, downsizing from 90,300 square feet at 300 Eagleview Boulevard to 9,500 square feet at 350 Eagleview Boulevard. During the second quarter, pharmaceutical distributer AmerisourceBergen announced that it planned to keep its headquarters in Conshohocken.
    [Show full text]
  • Amerisourcebergen Customer Huddle December 2, 2020
    AmerisourceBergen Customer Huddle December 2, 2020 During the call, please submit questions via the Skype window. Both audio and visuals are available through the Skype Meeting Broadcast link and are accessible via any browser, either PC or mobile. Today’s Speakers Keyvan Nekouei Alexis Rose Sr. Director, Account Vice President, Experience & Clinical Health Systems Services During the call, please submit questions via the Skype Q&A window. Both audio and visuals are available through the Skype Meeting Broadcast link and are accessible via any browser, either PC or mobile. COVID-19 Updates COVID-19 Therapies NDC # ABC Item # Commercially Government Product Manufacturer (if commercially (if commercially Available? Allocated? available) available) Veklury (remdesivir) Gilead Sciences YES NO 61958-2901-02 10251685 Eli Lilly and Bamlanivimab NO YES N/A N/A Company Eli Lilly and 2mg: 0002-4182-30 2mg: 10251952 Olumiant (baricitinib) YES NO Company 1mg: 0002-4732-30 1mg: 10252013 Regeneron Casirivimab and Pharmaceuticals, NO YES N/A N/A Imdevimab Inc. 4 12/02/2020 CONFIDENTIAL COVID-19 Therapies Resources FDA Approval Additional Info regarding Healthcare Providers Patient Fact FDA Authorization Product OR EUA product access, dosage, Fact Sheet Sheet Letter Announcement clinical data Veklury Healthcare Providers FDA Authorization FDA Approval Patient Support Veklury Website (remdesivir) Resources Letter Patient Fact Sheet (ENG) EUA Healthcare Providers FDA Authorization Bamlanivimab Bamlanivimab Website Announcement Fact Sheet Letter Patient Fact
    [Show full text]
  • A Benchmark of Letters from Leadership Across
    A Benchmark of Letters from Leadership across: Proxy Statements Annual Reports Sustainability/ESG/CSR Reports Executive Summary This Executive Summary presents a high-level overview of letters from leadership across the investor communications spectrum from the proxy statement to the annual report and sustainability/ESG/CSR reports. These letters address investor interests, in part, by defining corporate culture, clarifying strategy and articulating company purpose. For an in-depth review of these letters, see our complimentary download at https://argyleteam.com/thinking.aspx. Sample We reviewed investor communications from a combined sample of the Dow 30 and Fortune 50, a total of 63* companies. • Proxy Statements: 37 of 63 or 59% • Annual Reports: 48 of 63 or 76% • Sustainability Reports: 48 of 63 or 76% * Fortune 50 companies Fannie Mae, Freddie Mac and State Farm Insurance did not publish any of these statements in 2019 or 2020. For more information about Argyle contact [email protected] A Benchmark of Letters from Leadership across Reports 1 Companies Included In Our Benchmark Companies in the Dow 30 NIKE, Inc. Companies in the Dow 30 and Fortune 50 ® Companies in the Fortune 50 2 A Benchmark of Letters from Leadership across Reports Overview Messages from Leadership across all Reports Company Proxy Statement Letter Annual Report Letter Sustainability Report Letter Other Report Letter 3M – Alphabet Responsible Supply Chain Report Amazon – American Express – AmerisourceBergen – Anthem – Apple Supplier Responsibility Report AT&T Diversity
    [Show full text]